Evaluation of individual and ensemble probabilistic forecasts of COVID-19 mortality in the United States EY Cramer, EL Ray, VK Lopez, J Bracher, A Brennen, ... Proceedings of the National Academy of Sciences 119 (15), e2113561119, 2022 | 218 | 2022 |
Modeling of future COVID-19 cases, hospitalizations, and deaths, by vaccination rates and nonpharmaceutical intervention scenarios—United States, April–September 2021 RK Borchering MMWR. Morbidity and Mortality Weekly Report 70, 2021 | 156 | 2021 |
Projected resurgence of COVID-19 in the United States in July—December 2021 resulting from the increased transmissibility of the Delta variant and faltering vaccination S Truelove, CP Smith, M Qin, LC Mullany, RK Borchering, J Lessler, ... Elife 11, e73584, 2022 | 43 | 2022 |
Impact of SARS-CoV-2 vaccination of children ages 5–11 years on COVID-19 disease burden and resilience to new variants in the United States, November 2021–March 2022: A multi … RK Borchering, LC Mullany, E Howerton, M Chinazzi, CP Smith, M Qin, ... The Lancet Regional Health–Americas 17, 2023 | 30 | 2023 |
Evaluation of the US COVID-19 Scenario Modeling Hub for informing pandemic response under uncertainty E Howerton, L Contamin, LC Mullany, M Qin, NG Reich, S Bents, ... Nature communications 14 (1), 7260, 2023 | 21 | 2023 |
Context-dependent representation of within-and between-model uncertainty: Aggregating probabilistic predictions in infectious disease epidemiology E Howerton, MC Runge, TL Bogich, RK Borchering, H Inamine, J Lessler, ... Journal of the Royal Society Interface 20 (198), 20220659, 2023 | 16 | 2023 |
In-person schooling and associated COVID-19 risk in the United States over spring semester 2021 KE Wiens, CP Smith, E Badillo-Goicoechea, KH Grantz, MK Grabowski, ... Science advances 8 (16), eabm9128, 2022 | 13 | 2022 |
The US COVID-19 and Influenza Scenario Modeling Hubs: delivering long-term projections to guide policy SL Loo, E Howerton, L Contamin, CP Smith, RK Borchering, LC Mullany, ... Epidemics 46, 100738, 2024 | 9 | 2024 |
Informing pandemic response in the face of uncertainty. An evaluation of the US COVID-19 Scenario Modeling Hub E Howerton, L Contamin, LC Mullany, MM Qin, NG Reich, SJ Bents, ... medRxiv, 2023.06. 28.23291998, 2023 | 9 | 2023 |
Title evaluation of FluSight influenza forecasting in the 2021–22 and 2022–23 seasons with a new target laboratory-confirmed influenza hospitalizations SM Mathis, AE Webber, TM León, EL Murray, M Sun, LA White, LC Brooks, ... Nature Communications 15 (1), 6289, 2024 | 7 | 2024 |
Challenges of COVID-19 Case Forecasting in the US, 2020–2021 VK Lopez, EY Cramer, R Pagano, JM Drake, EB O’Dea, M Adee, T Ayer, ... PLoS computational biology 20 (5), e1011200, 2024 | 7 | 2024 |
flepiMoP: The evolution of a flexible infectious disease modeling pipeline during the COVID-19 pandemic JC Lemaitre, SL Loo, J Kaminsky, EC Lee, C McKee, C Smith, S Jung, ... Epidemics 47, 100753, 2024 | 2 | 2024 |
Potential impact of annual vaccination with reformulated COVID-19 vaccines: lessons from the US COVID-19 Scenario Modeling Hub S Jung, SL Loo, E Howerton, L Contamin, CP Smith, EC Carcelén, K Yan, ... Plos Medicine 21 (4), e1004387, 2024 | 2 | 2024 |
Modeling of Future COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Rates and Nonpharmaceutical Intervention Scenarios—United States, April–September 2021 E Howerton, CP Smith | | |